More extensive lateral ND (levels IIV) is considered in patients with MEN2A and familial MTC in cases of tumors greater than 1 cm or central LN metastasis [6]
In findings from a randomized controlled trial published in the Journal of Diabetes Investigation , 32 adults with type 2 diabetes receiving liraglutide (Saxenda, Novo Nordisk) at baseline were randomly assigned to switch to semaglutide (Ozempic/Wegovy, Novo Nordisk) or dulaglutide (Trulicity, Eli Lilly) for 26 weeks
BPC-157 is not FDA-approved, so it cannot be legally prescribed or dispensed by any licensed healthcare provider
The authors concluded that while the combination showed limited effectiveness in the overall population, it might offer potential benefits for individuals with particular baseline features [76]
But dont worry this isnt likely to be an issue, since the pharmacy probably gave you a short-gauge needle that wouldnt reach the muscle layer, anyway